News
AZ, Daiichi get FDA nod for Dato-DXd in breast cancer
AstraZeneca and Daiichi Sankyo have claimed FDA approval for a second antibody-drug conjugate for breast cancer - TROP2-directed Datroway.
News
Amgen picks up key colorectal cancer okay for KRAS drug
Can a new FDA approval in colorectal cancer kickstart sales growth for Amgen's KRAS inhibitor Lumakras?
News
Ozempic tops new Medicare price negotiation list
On their way out the door, the Biden administration has dropped the list of the next 15 drugs to be negotiated by Medicare.
News
AZ's Calquence gets first-line OK in mantle cell lymphoma
AstraZeneca's BTK inhibitor Calquence is the first drug in the class to be approved in the US for first-line treatment of mantle cell lymphoma.
News
Santhera preps UK Duchenne drug launch after NICE says yes
Santhera will launch its new drug for Duchenne muscular dystrophy in the UK within the next few weeks after getting the green light for NHS coverage.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
